Hjem › Ikke-småcellet lungekreft › Virginia › Norfolk
Kliniske studier for Ikke-småcellet lungekreft i Norfolk, VA
7 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Norfolk (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekruttererFase 3
- Virginia Oncology Associates (VOA) ( Site 8101), Norfolk
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
RekruttererFase 3
- Virginia Oncology Associates, Norfolk
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
RekruttererFase 1/2
- Virginia Oncology Associates, Norfolk
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
RekruttererFase 1/2
- Virginia Oncology Associates, Norfolk
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 3
- Virginia Oncology Associates, Norfolk
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- USOR Virginia Oncology Associates, Norfolk
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
RekruttererFase 1
- Virginia Oncology Associates, Norfolk
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Norfolk
- Brystkreft16 studier
- Blærekreft8 studier
- Prostatakreft8 studier
- Abdominal aortaaneurisme7 studier
- Eggstokkreft7 studier
- Kreft (alle typer)7 studier
- Hjertesvikt7 studier
- Kardiovaskulær sykdom7 studier
- Spinal muskelatrofi6 studier
- Perifer arteriell sykdom5 studier
- Tripelnegativ brystkreft5 studier
- Akut myelogen leukemi5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.